NCT04551378
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years to 39 Years (Adult)
Location of Metastases: 
Additional Notes: Patient must have an Initial cancer diagnosis between the ages of 15 to 39; Patient must have received any cancer treatment at MD Anderson Cancer Center with data available in the MD Anderson Cancer Center Tumor Registry
Exclusions: 
https://ClinicalTrials.gov/show/NCT04551378